Best practices in molecular testing and targeted therapy for HR+/HER2- metastatic breast cancer

March 21, 2025 00:26:05
Best practices in molecular testing and targeted therapy for HR+/HER2- metastatic breast cancer
COR2ED - Oncology Medical Conversation
Best practices in molecular testing and targeted therapy for HR+/HER2- metastatic breast cancer

Mar 21 2025 | 00:26:05

/

Show Notes

This podcast explores the best practices in molecular testing and targeted therapy for HR+/HER2- metastatic breast cancer.  

Dr Rena Callahan and Dr Roberto Salgado discuss key biomarkers, testing methods, and clinical decision-making, offering expert insights on how to optimise precision medicine.  

Topics include liquid vs. tumour biopsy, single gene vs. broad panel testing, and regional differences in testing practices.  

Tune in for a practical, expert-led discussion on how molecular testing can guide personalised treatment and improve patient outcomes. 

 

Key clinical takeaways: 

 

You can also watch a video of the experts in conversation and download the accompanying transcript on our website: https://cor2ed.com/precision-oncology-connect/programmes/molecular-testing-targeted-therapy-metastatic-breast-cancer/?media=0

Or watch on YouTube: https://www.youtube.com/watch?v=CTnXmh1oDwQ

Follow us on social media: 

LinkedIn: https://www.linkedin.com/company/ntrk-connect/  

X: https://x.com/PresOnc_Connect  

This content is intended for healthcare professionals only. 

The medical experts in this podcast are expressing their own views and not those of COR2ED, Supporters or their institution.  This podcast is supported by an Independent Education Grant from Thermo Fisher Scientific. 

This podcast is developed by cor2ed.com 

Published March 2025 

Subscribe to this channel to stay up to date with new Independent Education programmes as they’re released. 

Other Episodes

Episode

December 06, 2023 00:16:16
Episode Cover

Gastric and GEJ cancers: Clinical case discussions. Part 2 - metastatic disease

This podcast series consists of two episodes where expert oncologists Dr Sam Klempner (Massachusetts General Hospital, USA) and Dr Lizzy Smyth (Oxford University Hospitals...

Listen

Episode

December 06, 2023 00:22:00
Episode Cover

GI cancer: Management of skin toxicity from multikinase inhibitors

In this podcast, Beth Wittmer RN, Director of Care Management at Florida Cancer Specialists, USA and Prof. Hans Prenen, GI Medical Oncologist from Antwerp...

Listen

Episode

November 25, 2024 00:23:25
Episode Cover

Testing to treatment of BRAF-mutant metastatic NSCLC

 Testing to treatment of BRAF-mutant metastatic NSCLC    In this educational podcast episode, experts Prof. David Planchard and Dr Federico Cappuzzo discuss the significance of...

Listen